Rmb Capital Management, LLC Pfizer Inc Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rmb Capital Management, LLC holds 55,770 shares of PFE stock, worth $1.49 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

55,770

Previous 53,283 4.67%

Holding current value

$1.49 Million

Previous $1.49 Million 8.26%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $68,889 - $78,066	2,487 Added 4.67%	55,770 $1.61 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $48,650 - $57,009	1,926 Added 3.75%	53,283 $1.49 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $441,217 - $506,658	17,042 Added 49.66%	51,357 $1.43 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2,900 - $3,767	-111 Reduced 0.32%	34,315 $987,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $30,100 - $35,184	-938 Reduced 2.65%	34,426 $1.14 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $23,478 - $27,163	650 Added 1.87%	35,364 $1.3 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $399,887 - $520,594	10,152 Added 41.33%	34,714 $1.42 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $7,139 - $9,319	-171 Reduced 0.69%	24,562 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $166,638 - $203,423	3,808 Added 18.2%	24,733 $1.08 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $8,514 - $10,096	183 Added 0.88%	20,925 $1.1 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $915 - $1,133	-20 Reduced 0.1%	20,742 $1.07 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $462,907 - $686,183	-11,203 Reduced 35.05%	20,762 $1.23 Million
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $20,645 - $26,520	526 Added 1.67%	31,965 $1.38 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $21,689 - $24,570	604 Added 1.96%	31,439 $1.23 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $41,427 - $46,721	-1,237 Reduced 3.86%	30,835 $1.12 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $9,538 - $12,129	285 Added 0.9%	32,072 $1.18 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $18,002 - $21,120	-567 Reduced 1.75%	31,787 $1.17 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $23,343 - $28,318	-775 Reduced 2.34%	32,354 $1.06 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $885,448 - $1.27 Million	-32,758 Reduced 49.72%	33,129 $1.08 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $40,195 - $45,616	-1,221 Reduced 1.82%	65,887 $2.58 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $14,360 - $18,621	442 Added 0.66%	67,108 $2.41 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $332,117 - $372,891	-8,981 Reduced 11.87%	66,666 $2.89 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $2.34 Million - $2.57 Million	-62,494 Reduced 45.24%	75,647 $3.21 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $1.08 Million - $1.24 Million	-28,163 Reduced 16.93%	138,141 $6.03 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $3.09 Million - $3.75 Million	89,785 Added 117.34%	166,304 $7.33 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $3.84 Million - $4.09 Million	-116,355 Reduced 60.33%	76,519 $0
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $389,812 - $452,236	-12,216 Reduced 5.96%	192,874 $6.85 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $449,641 - $477,085	13,519 Added 7.06%	205,090 $7.43 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $3.53 Million - $3.89 Million	113,938 Added 146.76%	191,571 $6.84 Million
Q2 2017 Aug 14, 2017	BUY	N/A	77,633	77,633 $2.61 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account

Rmb Capital Management, LLC Pfizer Inc Transaction History